Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
AssigneePfizer Inc.
InventorsStéphane Caron, Enrique Vasquez
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel process for the preparation of a diastereomeric mixture of piperidinylaminomethyl trifluoromethyl cyclic ether compounds of formulae Ia and Ib: and pharmaceutically acceptable salts thereof, wherein R1 is C1-C6 alkyl; R2 is C1-C6 alkyl, halo C1-C6 alkyl or phenyl or substituted phenyl; R3 is hydrogen or halo; m is zero, one or two, and wherein said mixture is highly enriched in the compound of formula Ia, and to novel processes for the preparation and purification of intermediate compounds useful in the preparation of compounds of formulae Ia and Ib.
Claims5
A process for preparing a mixture of compounds of formulae Ia and Ib:
- enriched in the compound of formula Ia, and pharmaceutically acceptable salts thereof, wherein
- R1 is C1-C6 alkyl;
- R2 is C1-C6 alkyl, halo C1-C6 alkyl or phenyl or substituted phenyl;
- R3 is hydrogen or halo;
- m is zero, one or two;
- comprising the steps of
- (a1) reacting a mixture of compounds of formulae Ia and Ib:
- with an acid of formula HX, wherein HX is selected from the group consisting of (S)-(+)-mandelic acid, D-(−)-tartaric acid, di-p-toluoyl-D-tartaric acid, ((1R)-endo,anti)-(+)-3-bromocamphor-8-sulfonic acid, quinic acid, acetic acid and hydrobromic acid, to form a mixture of diastereomeric compounds of formulae Va and Vb, respectively:
- (b1) permitting the HX salt of the diastereomeric product mixture of step (a1) to crystallize out of a solution thereof in an appropriate solvent;
- (c1) treating the resulting mixture of compounds obtained from step (b1) with a base to obtain a mixture of compounds Ia and Ib, that is enriched in the compound of formula Ia.
Dependencies are inferred from the claim text.